Procept Historical Cash Flow
| PRCT Stock | USD 58.35 0.58 0.98% |
Analysis of Procept Biorobotics cash flow over time is an excellent tool to project Procept Biorobotics Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 174.4 M or Other Cashflows From Financing Activities of 26.4 M as it is a great indicator of Procept Biorobotics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Procept Biorobotics Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Procept Biorobotics Corp is a good buy for the upcoming year.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procept Biorobotics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. About Procept Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Procept balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Procept's non-liquid assets can be easily converted into cash.
Procept Biorobotics Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Procept Biorobotics Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Procept Biorobotics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Procept Biorobotics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Procept Biorobotics Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procept Biorobotics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Procept Biorobotics' Change To Inventory is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 33.4 M in 2025, whereas Net Borrowings is likely to drop slightly above 1 M in 2025.
| 2024 | 2025 (projected) | Stock Based Compensation | 31.8M | 33.4M | Net Borrowings | 1.1M | 1.0M |
Procept Biorobotics cash flow statement Correlations
Click cells to compare fundamentals
Procept Biorobotics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Procept Biorobotics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (3.1M) | (6.1M) | (15.3M) | (9.8M) | 1.9M | 2.0M | |
| Investments | (233K) | (592K) | (2.7M) | (17.4M) | (4.4M) | (4.2M) | |
| Change In Cash | 58.2M | 204.2M | (79.4M) | 34.6M | 76.5M | 42.7M | |
| Stock Based Compensation | 2.2M | 3.8M | 10.3M | 19.1M | 31.8M | 33.4M | |
| Free Cash Flow | (48.6M) | (57.9M) | (83.0M) | (133.2M) | (103.6M) | (108.8M) | |
| Change In Working Capital | (483K) | (4.7M) | (11.5M) | (26.2M) | (47.3M) | (45.0M) | |
| Begin Period Cash Flow | 42.7M | 100.9M | 305.1M | 225.7M | 260.3M | 174.4M | |
| Total Cashflows From Investing Activities | (233K) | (592K) | (2.7M) | (25.2M) | (4.4M) | (4.2M) | |
| Other Cashflows From Financing Activities | 82.1M | 89.8M | 2.4M | 6.1M | 15.6M | 26.4M | |
| Depreciation | 2.9M | 3.3M | 2.8M | 3.8M | 5.2M | 3.6M | |
| Other Non Cash Items | (97K) | (345K) | 5.1M | 1.1M | 2.5M | 2.6M | |
| Capital Expenditures | 233K | 592K | 2.7M | 25.2M | 4.4M | 7.5M | |
| Total Cash From Operating Activities | (48.3M) | (57.3M) | (80.4M) | (108.0M) | (99.2M) | (104.2M) | |
| Change To Account Receivables | (511K) | (2.9M) | (10.8M) | (33.1M) | (36.0M) | (34.2M) | |
| Issuance Of Capital Stock | 76.5M | 257.1M | (45K) | 161.7M | 164.5M | 121.0M | |
| Net Income | (53.0M) | (59.9M) | (87.2M) | (105.9M) | (91.4M) | (96.0M) | |
| Total Cash From Financing Activities | 106.8M | 262.1M | 3.6M | 167.8M | 180.1M | 136.9M | |
| End Period Cash Flow | 100.9M | 305.1M | 225.7M | 260.3M | 336.8M | 233.1M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.